within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A07D_Antipropulsives.A07DA06_Eluxadoline;

model Eluxadoline
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.01,
    Cl = 0.00016277777777777777,
    adminDuration = 600,
    adminMass = 100 / 1000000,
    adminCount = 1,
    Vd = 0.0437,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.016666666666666666,
    Tlag = 0);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Eluxadoline</td></tr><tr><td>ATC code:</td><td>A07DA06</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>100</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>43.7</td><td>L</td></tr>
    <tr><td>clearance:</td><td>586</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Eluxadoline is a mixed mu-opioid receptor agonist and delta-opioid receptor antagonist, utilized for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults. It acts locally in the gastrointestinal tract, reducing bowel contractions and inhibiting pain signals. Eluxadoline is approved by regulatory agencies such as the FDA and EMA.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic data based on healthy adult subjects following oral administration of eluxadoline 100 mg.</p><h4>References</h4><ol><li><p>Bonifacio, L, et al., &amp; Covington, PS (2018). Evaluation of Eluxadoline Effect on Cardiac Repolarization. <i>Clinical pharmacology in drug development</i> 7(7) 727–736. DOI:<a href=\"https://doi.org/10.1002/cpdd.453\">10.1002/cpdd.453</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29659201/\">https://pubmed.ncbi.nlm.nih.gov/29659201</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.A.A07DA06 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Eluxadoline;
